Abstract
For patients with ischemic stroke there is benefit to early treatment (within 3 hours) with recombinant tissue plasminogen activator, rt-PA, an FDA approved thrombolytic drug.
© 1999 Optical Society of America
PDF ArticleMore Like This
O. Steinkellner, H. Wabnitz, R. Macdonald, C. Gruber, J. Steinbrink, P. Brunecker, H. Müller, G. J. Jungehülsing, J. B. Fiebach, and H. Obrig
BTuB5 Biomedical Optics (BIOMED) 2010
Peyman Zirak, Raquel Delgado-Mederos, Igor Blanco, Lavinia Dinia, David Carrera, Joan Martí-Fàbregas, and Turgut Durduran
BM3A.11 Biomedical Optics (BIOMED) 2014
Ashwin B Parthasarathy, Steve S Schenkel, David R Busch, Kenneth Abramson, Julien Menko, Wesley B Baker, Malavika Chandra, Michael Mullen, John A Detre, and Arjun G Yodh
BW2B.5 Biomedical Optics (BIOMED) 2014